Di Wei

533 total citations
25 papers, 282 citations indexed

About

Di Wei is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Di Wei has authored 25 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Neurology. Recurrent topics in Di Wei's work include Reproductive Biology and Fertility (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Advanced Welding Techniques Analysis (2 papers). Di Wei is often cited by papers focused on Reproductive Biology and Fertility (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Advanced Welding Techniques Analysis (2 papers). Di Wei collaborates with scholars based in China, India and Italy. Di Wei's co-authors include Yaocheng Zhang, Li Yang, Shengnan Gao, Tao Meng, Xuying Li, Yongyi Chen, Min Zhang, Xiaomei Zhu, Qinqin Cheng and Ying Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Materials Science and Engineering A and Fertility and Sterility.

In The Last Decade

Di Wei

25 papers receiving 276 citations

Peers

Di Wei
Comparison fields: 5 of 89
  • Mechanical Engineering 89
  • Molecular Biology 51
  • Health 34
  • Rehabilitation 31
  • Automotive Engineering 28
Replace Yi Lai with:
Yi Lai China
Caixia Jiang China
Benjamin Wheatley United States
Katie Glover United Kingdom
Ziwei Sun China
Mojca Čižek Sajko Slovenia
Hassan Nazari Iran
F Dittrich Germany
Johnson Hsin-Chung Cheng Taiwan
Graeme R. Paul Switzerland
Yi Lai China View profile →
Citations per field, relative to Di Wei
Di Wei · 1×
Citations per year, relative to Di Wei
Di Wei · 1×

Countries citing papers authored by Di Wei

Since Specialization
Citations

This map shows the geographic impact of Di Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Wei more than expected).

Fields of papers citing papers by Di Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Wei. The network helps show where Di Wei may publish in the future.

Co-authorship network of co-authors of Di Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Di Wei. A scholar is included among the top collaborators of Di Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Wei. Di Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 3
2 8
3 4
4 1
5 34
6 9
7 25
8 3
9 5
10
Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo
1
11 43
12 6
13
The 19 Fr. Intrauterine Bigatti Shaver (IBS®): a clinical and technical update.
6
14 6
15
ROS-INDUCED OXIDATIVE STRESS IN NOBILE-TYPE DENDROBIUM PROTOCORM-LIKE BODIES (PLBS) DURING VITRIFICATION.
11
16
Reliability and validity of the Chinese version of the functional assessment of chronic illness therapy-spiritual well-being in cancer patients
12
17
Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy
6
18 1
19 9
20
[Immune reconstitution in advanced ovarian cancer patients undergoing first line chemotherapy].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026